My Alcon | Canada

This page is available in English. Select below for other countries.

Select Another Country

 

Clareon® Toric IOL

 

SEE DIFFERENTLY, with Maximum Stability

 

Clareon® Toric IOL

 

SEE DIFFERENTLY, with Maximum Stability

 

 

Clareon® Toric IOLs provide exceptional clarity1-5*, allowing you to confidently deliver the long-lasting refractive outcomes that your 
patients expect.

 

Alt text
Alt text

Exceptional Clarity that Lasts4,6†
 

Delivers among the lowest levels of glistenings, SSNGs, and surface haze.4,6-8† In long-term clinical studies, Clareon® IOLs were reported as glistening-free over 3 and 9 years.6,9†

Alt text
Alt text

Exceptional Rotational Stability1,10
 

Rotational stability you expect from the very beginning.1,10

Alt text
Alt text

Maximum Refractive Predictability2,11

 

 

STABLEFORCE® haptics for superior axial stability and centration.1,2,11

Alt text
Alt text

Optical Design with Proven Performance12

 

Clareon® and AcrySof® share the same -0.2µm aspheric design resulting in improved depth of focus with a fully usable 6mm optic.12††

See the difference with the 
Clareon® Toric IOL

 

The Clareon® Toric IOL utilizes a new hydrophobic acrylic BioMaterial and advanced manufacturing process to deliver a pristine IOL.1-4

 

 

STABLEFORCE® haptics provide a biomechanical advantage

 

Clareon® Toric IOLs deliver the rotational stability you expect from the very beginning.1.10

‡ In an additional analysis, 98.4% of Clareon® IOLs (n=127 ) had an absolute rotation of ≤10° between surgery and 6 months.

 

‡‡ Mean rotation at day 1 (n=127 ) and 6 months (n=124 ): 1 .8° ± 3 .7° and 2 .3° ± 3 .9°, respectively. Study measures were taken at baseline (immediately after surgery, <1 hour ), at day 1, and at months 1, 3, and 6.

Exceptional axial stability1,2,15 for a range of capsule sizes

Gray Background Image of man by the ocean

Clareon® Toric Offers Excellent Distance and Functional Intermediate Vision1

 

Minimal axial shift in capsules as small as 9 mm for refractive stability

Alt text
Alt text

Clareon® compressed at 9 mm

Alt text
Alt text

Clareon® uncompressed

No significant difference in range of vision was observed between Clareon® and Eyhance monofocals

 

In a clinical study of 310 patients (155 per group), Clareon® and Eyhance IOLs offered comparable binocular range of vision16**

Gray Background Image of man by the ocean

** Based on a non-interventional, examiner masked comparative study (n=155 per group) on binocular visual acuities in distance, intermediate and defocus curves. Non-inferiority (1 EDTRS line) confirmed with step down statistical of multiple VA. Trademarks are the property of their respective owners.​

Clareon® IOLs: Consistent outcomes you can trust

 

Based on two studies with a total of 184 patients, Clareon® IOLs deliver predictable range of vision 
while maintaining 20/20 visual acuity at distance16,17

alt text

Explore additional resources for the Clareon® Toric IOLs

The Clareon® collection provides more options for your astigmatic patients than any other platform in its class

Alt text
Alt text

Clareon® Monofocal Toric

 

Glistening-free BioMaterial with outstanding rotational stability and predictable placement.1,2,4,11

Alt text
Alt text

Clareon® PanOptix® Toric

 

The latest advancements in lens technology, offering a full range of vision and exceptional clarity.18,19*

Alt text
Alt text

Clareon® Vivity® Toric

 

The first and only non-diffractive presbyopia-mitigating IOL with exceptional clarity*, excellent intermediate vision, and functional near vision.4,20

Alcon online Clareon® Toric 
IOL calculator with the 
Barrett Algorithm

CLICK HERE

See Things Differently

Share our product brochure with your patients to communicate the Clareon® difference 
 

DOWNLOAD PATIENT BROCHURE

See Things Differently

Available on Clareon®: Alcon’s most advanced IOL BioMaterial to date

* Based on in vitro examinations of glistenings, surface haze and SSNGs.

† Defined as modified Miyata grade 0, <25mv /mm2 over 3 years (n=138 ), and over 9 years (n=20 ), respectively.

†† Clareon® and AcrySof® share the same -0.2μm aspheric design resulting in improved depth of focus.




IMPORTATN PRODUCT INFORMATION - CLAREON® ASPHERIC FAMILY OF HYDROPHOBIC ACRYLIC IOLS 

 

The Clareon® Toric Aspheric Hydrophobic Acrylic IOL with the AutonoMe® Pre-loaded Delivery System is intended for use by a trained ophthalmic surgeon for the replacement of the human crystalline lens during cataract surgery. Refer to the eDirections for Use for more information regarding indications, contraindications, warnings, precautions, and cautions. 

ATTENTION: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions. Accurate keratometry and biometry in addition to the use of the Alcon Online Toric Calculator (www.myalcon-toriccalc.com) are recommended to achieve optimal visual outcomes.

REFERENCES:

 

1. Clareon® Toric Directions for Use.
 

2. Alcon data on file, 2017.


3. Lee B, Chang D. Comparison of the rotational stability of two toric intraocular lenses in 1273 consecutive eyes. Ophthalmology. 2018;125(9):1325-1331.


4. Werner L, Thatthamla I, Ong M, et al. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL. J Cataract Refract Surg. 2019;45:1490-1497.


5. Das KK, Werner L, Collins S, Hong X. In vitro and schematic model eye assessment of glare or positive dysphotopsia-type photic phenomena: Comparison of a new material IOL to other monofocal IOLs. J Cataract Refract Surg. 2019;45(2):219-227.


6. Oshika T, Fujita Y, Inamura M, Miyata K. Mid-term and long-term clinical assessments of a new 1-piece hydrophobic acrylic IOL with hydroxyethyl methacrylate. J Cataract Refract Surg. 2020;46(5):682-687.


7. Alcon Data on File, 2020.


8. Stanojcic N, OʼBrart D, Hull C, et al. Visual and refractive outcomes and glistenings occurrence after implantation of 2 hydrophobic acrylic aspheric monofocal IOLs. J Cataract Refract Surg. 2020;46(7):986-994.


9. Maxwell A, Suryakumar R. Long-term effectiveness and safety of a three-piece acrylic hydrophobic intraocular lens modified with hydroxyethyl-methacrylate: an open-label, 3-year follow-up study. Clin Ophthalmol. 2018;12:2031-2037.
10. Alcon Data on File, 2019.


11. Lane S, Collins S, Das KK, et al. Evaluation of intraocular lens mechanical stability. J Cataract Refract Surg. 2019 Apr;45(4):501-506.


12. Alcon data on file, 2015.


13. Alcon data on file, 2017.


14. Lehmann R, Maxwell A, Lubeck DM, Fong R, Walters TR, Fakadej A. Effectiveness and Safety of the Clareon Monofocal Intraocular Lens: Outcomes from a 12-Month Single-Arm Clinical Study in a Large Sample. Clin Ophthalmol. 2021;15:1647-1657.


15. Alcon Data on File, 2017.


16. Alcon Data on File, 2023.


17. Alcon Data on File, 2022.


18. Clareon® PanOptix® Trifocal Hydrophobic Acrylic IOL Model CNWTT0 2021 Directions for Use.


19. Zhu D, Ren S, Mills K, Hull J, Dhariwal M. Rate of Complete Spectacle Independence with a Trifocal Intraocular Lens: A Systematic Literature Review and Meta-Analysis. Ophthalmol Ther. 2023;12(2):1157-1171.


20. Clareon® Vivity® Extended Vision Hydrophobic IOL (CNWET0) Directions for Use.